ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Chart of Core Grants

October 18, 1991

Reasons NIH Women Scientists Leave: Family Roles, Lower Confidence.

November 2, 2007

Stereo Mammography Detects More Lesions, Study Finds

December 28, 2007

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001